Annual Cash & Cash Equivalents
$189.52 M
+$101.87 M+116.23%
31 December 2023
Summary:
Cellebrite DI annual cash & cash equivalents is currently $189.52 million, with the most recent change of +$101.87 million (+116.23%) on 31 December 2023. During the last 3 years, it has risen by +$60.81 million (+47.24%). CLBT annual cash & cash equivalents is now at all-time high.CLBT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$136.35 M
+$29.39 M+27.48%
30 September 2024
Summary:
Cellebrite DI quarterly cash and cash equivalents is currently $136.35 million, with the most recent change of +$29.39 million (+27.48%) on 30 September 2024. Over the past year, it has dropped by -$717.00 thousand (-0.52%). CLBT quarterly cash and cash equivalents is now -28.05% below its all-time high of $189.52 million, reached on 31 December 2023.CLBT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLBT Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.2% | -0.5% |
| 3 y3 years | +47.2% | +24.1% |
| 5 y5 years | - | - |
CLBT Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +116.2% | -28.1% | +61.2% |
| 5 y | 5 years | at high | +147.6% | -28.1% | +61.2% |
| alltime | all time | at high | +147.6% | -28.1% | +61.2% |
Cellebrite DI Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $136.35 M(+27.5%) |
| June 2024 | - | $106.96 M(-12.6%) |
| Mar 2024 | - | $122.43 M(-35.4%) |
| Dec 2023 | $189.52 M(+116.2%) | $189.52 M(+38.3%) |
| Sept 2023 | - | $137.07 M(+24.0%) |
| June 2023 | - | $110.50 M(+11.6%) |
| Mar 2023 | - | $98.97 M(+12.9%) |
| Dec 2022 | $87.64 M | $87.64 M(+3.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $84.57 M(-7.8%) |
| June 2022 | - | $91.69 M(-27.1%) |
| Mar 2022 | - | $125.72 M(-13.9%) |
| Dec 2021 | $145.97 M(+13.4%) | $145.97 M(+32.8%) |
| Sept 2021 | - | $109.89 M(-33.9%) |
| June 2021 | - | $166.29 M(+29.2%) |
| Dec 2020 | $128.71 M(+68.1%) | $128.71 M |
| Dec 2019 | $76.55 M | - |
FAQ
- What is Cellebrite DI annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cellebrite DI?
- What is Cellebrite DI annual cash & cash equivalents year-on-year change?
- What is Cellebrite DI quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cellebrite DI?
- What is Cellebrite DI quarterly cash and cash equivalents year-on-year change?
What is Cellebrite DI annual cash & cash equivalents?
The current annual cash & cash equivalents of CLBT is $189.52 M
What is the all time high annual cash & cash equivalents for Cellebrite DI?
Cellebrite DI all-time high annual cash & cash equivalents is $189.52 M
What is Cellebrite DI annual cash & cash equivalents year-on-year change?
Over the past year, CLBT annual cash & cash equivalents has changed by +$101.87 M (+116.23%)
What is Cellebrite DI quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLBT is $136.35 M
What is the all time high quarterly cash and cash equivalents for Cellebrite DI?
Cellebrite DI all-time high quarterly cash and cash equivalents is $189.52 M
What is Cellebrite DI quarterly cash and cash equivalents year-on-year change?
Over the past year, CLBT quarterly cash and cash equivalents has changed by -$717.00 K (-0.52%)